Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 796-801

  Lee, A H S ^a,b   Happerfield, L C ^a   Millis, R R ^a   Bobrow, L G ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Carcinoma of breast; Ductal carcinoma; Immunohistochemistry; Inflammation; Lobular carcinoma; Lymphoctic lobulitis

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; B LYMPHOCYTE; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUNG CARCINOMA; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029740485     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.438     Document Type: Article

References (40)

1. AALTOMA S, LIPPONEN P, ESKELINEN M, KOSMA V-M, MARIN S, ALHAVA E AND SYRJANEN K. (1992). Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur. J. Cancer, 28A, 859-864.
2. ALDERSON MR, HAMLIN I AND STAUNTON MD. (1971). The relative significance of prognostic factors in breast carcinoma. Br. J. Cancer, 25, 646-656.
3. AN T, SOOD U, PIETRUK T, CUMMINGS G, HASHIMOTO K AND CRISSMAN JD. (1987). In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic factors. Am. J. Pathol., 128, 52-60.
4. AZZOPARDI JG. (1979). Problems in Breast Pathology. London: WB Saunders.
5. BALCH CM, RILEY LB, BAE YJ, SALMERON MA, PLATSOUCAS CD, VON ESCHENBACH A AND ITOH K. (1990). Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch. Surg., 125, 200-205.
6. BARTEK J, PETREK M, VOJTESEK B. BARTKOVA J, KOVARIK J AND REJTHAR A. (1987). HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. Br. J. Cancer, 56, 727-733.
7. BHAN AK AND DESMARAIS CL. (1983). Immunohistologic characterisation of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst., 71, 507-516.
8. BLACK MM AND SPEER FD. (1955). Periductal lymphoid infiltrations in mammary tissue. Arch. Pathol., 60, 457 461.
9. BLACK MM, BARCLAY THC AND HANKEY BF. (1975). Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer, 36, 2048-2055.
10. CHETTY R AND BUTLER AE. (1993). Lymphocytic mastopathy associated with infiltrating lobular breast carcinoma. J. Clin. Pathol., 46, 376-377.
11. DVORAK HF, DICKERSIN GR, DVORAK AM, MANSEAU EJ AND PYNE K. (1981). Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J. Natl Cancer Inst., 67, 335-345.
12. ELSTOW CW AND ELLIS IO. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410.
13. ELSTON CW, GRESHAM GA, RAO GS, ZEBRO T, HAYBITTLE JL, HOUGHTON J AND KEARNEY G. (1982). The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: clinico-pathological aspects. Br. J. Cancer, 45, 655-669.
14. FISHER ER, GREGORIO RM, FISHER B, REDMOND C, VELLIOS F, SOMMERS SC AND COOPERATING INVESTIGATORS. (1975). The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No. 4). Cancer, 36, 1-85.
15. FISHER ER, KOTWAL N, HERMANN C, FISHER B AND CONTRIBUTING INVESTIGATORS OF THE NATIONAL SURGICAL ADJUVANT BREAST PROJECT. (1983). Types of tumor lymphoid response and sinus histiocytosis. Relationship to five-year, disease-free survival in patients with breast cancer. Arch. Pathol. Lab. Med., 107, 222-227.
16. GIORNO R. (1983). Mononuclear cells in malignant and benign human breast tissue. Arch. Pathol. Lab. Med., 107, 415-417.
17. GOTTLINGER HG, RIEBER P, GOKEL JM, LOHE KJ AND RIETH-MULLER G. (1985). Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int. J. Cancer, 35, 199-205.
18. HAGEMEIER H-H, VOLLMER E, GOERDT S, SCHULZE-OSTHOFF K AND SORG C. (1986). A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non-reactive with normal adult tissues. Int. J. Cancer, 38, 481-488.
19. HORNY H-P AND HORST H-A. (1986). Lymphoreticular infiltrates in invasive ductal breast cancer. Virchows. Arch. A Pathol. Anat., 409, 275-286.
20. HURLIMANN J AND SARAGA P. (1985). Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int. J. Cancer, 35, 753-762.
21. KURTZ JM, JACQUEMIER J, AMALRIC R, BRANDONE H, AYME Y, HANS D, BRESSAC C AND SPITALIER J-M. (1990). Why are local recurrences after breast-conserving therapy more frequent in younger patients? J. Clin. Oncol., 8, 591-598.
22. LAMMIE GA, BORROW LG, STAUNTON MDM, LEVISON DA, PAGE G AND MILLIS RR. (1991). Sclerosing lymphocytic lobulitis of the breast evidence for an autoimmune pathogenesis. Histopathology, 19, 13-20.
23. LAMPEJO OT, BARNES DM, SMITH P AND MILLIS RR. (1994). Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin. Diagn. Pathol., 11, 215-222.
24. LAUDER I, AHERNE W, STEWART J AND SAINSBURY R. (1977). Macrophage infiltration of breast tumours: a prospective study. J. Clin. Pathol., 30, 563-568.
25. LEE AHS, MILLIS RR AND BOBROW LG. (1996). Lymphocytic lobulitis and carcinoma of the breast. (letter). Histopathology, 28, 94-95.
26. LUCIN K, ITERNICKE Z AND JONJIC N. (1994). Prognostic-significance of T-cell infiltrates, expression of β2-microglobulin and HLA-DR antigens in breast carcinoma. Pathol. Res. Pract., 190, 1134 1140.
27. LWIN KY, ZUCCARINI O, SLOANE JP AND BEVERLEY PCL. (1985). An immunohistochemical study of leukocyte localisation in benign and malignant breast tissue. Int. J. Cancer, 36, 433-438.
28. MIESCHER S, WHITESIDE TL, CARREL S AND VON FLIEDNER V. (1986). Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136, 1899-1907.
29. PARL FE AND DUPONT WD. (1982). A retrospective cohort study of histologic risk factors in breast cancer patients. Cancer, 50, 2410-2416.
30. RAMACHANDRA S, MACHIN L, ASHLEY S, MONAGHAN P AND GUSTERSON BA. (1990). Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma - a detailed morphological analysis. J. Pathol., 161, 7-14.
31. RILKE F, COLNAGHI MI, CASCINELLI N, ANDREOLA S, BALDINI MT, BUFALINO R, DELLA PORTA G, MENARD S, PIEROTTI MA AND TESTORI A. (1991). Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int. J. Caner, 49, 44-49.
32. ROSES DF, BELL DA, FLOTTE TJ, TAYLOR R, RATECH H AND DUBIN N. (1982). Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. Am. J. Clin. Pathol., 78, 817 820.
33. SCHOLL SM, PALLUD C, BEUVON F, HACENE K, STANLEY ER, ROHRSCHNEIDER L, TANG R, POUILLART P AND LIDEREAU R. (1994). Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J. Natl Cancer Inst., 86, 120-126.
34. SCHWARTZ IS AND STRAUCHEN JA. (1990). Lymphocytic mastopathy. An autoimmune disease of the breast? Am. J. Clin. Pathol., 93, 725-730.
35. SYRJANEN KJ AND HJELT LH. (1978). Tumor-host interrelationships in carcinoma of the female breast. Surg. Gynecol. Obstet., 147, 43-48.
36. UNDERWOOD JCE. (1974). Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br. J. Cancer, 30, 538-547.
37. + macrophages in antitumor cytotoxicity. Lab. Invest., 67, 166-174.
38. VON KLEIST S, BERLING J, BOHLE W AND WITTEKIND C. (1987). Immunohistochemical analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions. Int. J. Cancer, 40, 18-23.
39. WANG JM, KUMAR S, PYE D, VAN AGTHOVEN AJ, KRUPINSKI J AND HUNTER RD. (1993). A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int. J. Cancer, 54, 363 370.
40. ZUK JA AND WALKER RA. (1987). Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J. Pathol., 152, 275-285.